ROAD AHEAD

The Indian pharmaceutical market size is expected to grow to US$ 100 billion by
2025, driven by increasing consumer spending, rapid urbanisation,
and raising healthcare insurance among others.

The Indian government has taken many steps to reduce costs and bring down
healthcare expenses. Speedy introduction of generic drugs into the market has
remained in focus and is expected to benefit the Indian pharmaceutical
companies. In addition, the thrust on rural health programmes,
lifesaving drugs and preventive vaccines also augurs well for the
pharmaceutical companies.